Neopro 325 81.25 g / 100 g Powder For Solution is a Health Canada–registered veterinary drug (DIN 02530619) held by Can-Vet Animal Health Supplies Ltd., containing Neomycin Sulfate. Health Canada lists its status as Marketed (status date 27 Sep 2022). Nexara Health has matched 114 registrations of Neomycin Sulfate across 11 other regulated markets.
Health Canada registration
| DIN | 02530619 |
|---|---|
| Brand name | Neopro 325 |
| Active ingredient | Neomycin Sulfate |
| Strength | 81.25 g / 100 g |
| Dosage form | Powder For Solution |
| Route | Oral |
| Company | Can-Vet Animal Health Supplies Ltd. |
| Status | Marketed — 27 Sep 2022 |
| Class | Veterinary |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Neomycin Sulfate registered in other markets
114 registrations of the same molecule in 11 national registries outside Canada (first 48 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Bulgaria | Neomycinum TС | Tarchomin Pharmaceutical Works "Polfa" S.A. | 11.72 mg/g cutaneous spray, suspension | спрей дермален, суспенсия | По лекарско предписание | BDA |
| Denmark | Neomay | Laboratorios Maymo S.A.U. | 500.000 IE/g | pulver til anvendelse i drikkevand/mælk | Decentral procedure | Laegemiddelstyrelsen |
| Denmark | Novosol | Huvepharma | 500.000 IE/g | pulver til anvendelse i drikkevand/mælk | Decentral procedure | Laegemiddelstyrelsen |
| Hong Kong | Neoate Tab 250mg | Apt Pharma Limited | Registered | DH Drug Office | ||
| Hong Kong | Neomycin Cream 0.5% | Christo Pharm Ltd | Registered | DH Drug Office | ||
| Hong Kong | Neomycin Cream 0.5% W/W | Vickmans Laboratories Ltd | Registered | DH Drug Office | ||
| Hong Kong | Neomycin Cream 1% | Meyer Pharmaceuticals Ltd | Registered | DH Drug Office | ||
| Hong Kong | Neomycin Cream 1% | Neochem Pharmaceutical Laboratories Ltd. | Registered | DH Drug Office | ||
| Hong Kong | Rexom Neomycin Cream 0.5% W/W | Wa Man (Hk) Limited | Registered | DH Drug Office | ||
| Hong Kong | Uni-Neoderm Cream 1% | Marching Pharmaceutical Limited | Registered | DH Drug Office | ||
| Iceland | Neomycin | Parlogis - óskráð lyf | 500 mg | töflur | 0 | Lyfjastofnun lyfjaverdskra |
| Norway | Neomycin amdipharm tab 500 mg | Amdipharm | 100 | Tablett | Aktiv oppføring | FEST (DMP) |
| Norway | Neomycin sulfate teva tab 500 mg | Teva | 100 | Tablett | Aktiv oppføring | FEST (DMP) |
| Poland | Nemicina | S.p. Veterinaria S.a. | 500000 j.m./g | Proszek do podania w wodzie do picia / w mleku | Bezterminowe | URPL RPL |
| Poland | Neoactive | Laboratorios e Industrias IVEN, S.A. | 500000 IU/1 g | Proszek do podania w wodzie do picia / preparacie mlekozastępczym | Bezterminowe | URPL RPL |
| Poland | Neobiotic | Tarchomińskie Zakłady Farmaceutyczne "Polfa" S.A. | 11,72 mg/g | Aerozol na skórę, zawiesina | Bezterminowe | URPL RPL |
| Poland | Neofort | Biofaktor Sp. z o.o. | 700 mg/g | Proszek do sporządzania roztworu doustnego | Bezterminowe | URPL RPL |
| Poland | Neomay | Laboratorios Maymó, S.A.U. | 500000 IU/1 g | Proszek do podania w wodzie do picia / preparacie mlekozastępczym | Bezterminowe | URPL RPL |
| Poland | Neomycinum Jelfa | Bausch+Lomb Ireland Ltd. | 5 mg/g | Maść do oczu | Bezterminowe | URPL RPL |
| Poland | Neomycinum TZF | Tarchomińskie Zakłady Farmaceutyczne "Polfa" S.A. | 11,72 mg/g | Aerozol na skórę, zawiesina | Bezterminowe | URPL RPL |
| Poland | Neomycinum TZF | Tarchomińskie Zakłady Farmaceutyczne "Polfa" S.A. | 250 mg | Tabletki | Bezterminowe | URPL RPL |
| Saudi Arabia | Neomycin Nasal Spray | — | 0.5 | Inactive | SFDA | |
| Saudi Arabia | Statrol Eye Drops | — | 3.5 | Inactive | SFDA | |
| Taiwan | "Purzer" Neocream Ointment 5mg/g (Neomycin) | 健康化學製藥股份有限公司 | 軟膏劑 | Registered | TFDA | |
| Taiwan | Chiafra Tulle | 培力藥品工業股份有限公司 | 紗布敷料劑 | 已註銷 | TFDA | |
| Taiwan | Fradio Ointment | Nippon Kayaku Co.,Ltd. | 軟膏劑 | 已註銷 | TFDA | |
| Taiwan | Fradio Ointment | Nippon Kayaku Co.,Ltd. | 軟膏劑 | 已註銷 | TFDA | |
| Taiwan | Fradio Ointment | Nippon Kayaku Company Ltd. | 軟膏劑 | 已註銷 | TFDA | |
| Taiwan | Fradiomycin For Topical Solution | Nippon Kayaku Co.,Ltd. | 外用粉劑 | 已註銷 | TFDA | |
| Taiwan | Fradiomycin Powder | Nippon Kayaku Co.,Ltd. | 散劑 | 已註銷 | TFDA | |
| Taiwan | Fradiomycin Sulfate | Meiji Seika, Kaisha Ltd. (Yodogawa Factory) | （粉） | 已註銷 | TFDA | |
| Turkey | Thiocilline 30 Gr Deri Pomadi | Abdi̇ İbrahi̇m İlaç Sanayi̇ Ve Ti̇caret A.ş | Aktif | TITCK | ||
| United Kingdom | Neomycin 0.25% / Gramicidin 0.025% ointment | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Neomycin 0.35% / Triamcinolone 0.1% ear drops | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Neomycin 0.5% / Betamethasone 0.1% eye ointment | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Neomycin 0.5% / Chlorhexidine hydrochloride 0.1% nasal cream | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Neomycin 0.5% cream | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Neomycin 0.5% eye drops | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Neomycin 0.5% eye drops 0.5ml unit dose preservative free | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Neomycin 0.5% eye ointment | — | 0001 | NHS dm+d VMP | ||
| United States | Antibiotic | Total Resources International | Ointment | listed | FDA NDC | |
| United States | First Aid Only Neomycin Antibiotic | Acme United Corporation | Ointment | listed | FDA NDC | |
| United States | neomycin sulfate | Isomedix Operations Inc | Powder | FDA NDC | ||
| United States | neomycin sulfate | Isomedix Operations, Inc | Powder | FDA NDC | ||
| United States | neomycin sulfate | Isomedix Operations Inc | Powder | FDA NDC | ||
| United States | neomycin sulfate | Isomedix Operations Inc | Powder | FDA NDC | ||
| United States | Neomycin Sulfate | Shaanxi Shuvita Biotech Co., Ltd | Granule | listed | FDA NDC | |
| United States | Neomycin Sulfate | Medisca Inc. | Powder | FDA NDC |
See every manufacturer of Neomycin Sulfate worldwide →
Regulator price references for Neomycin Sulfate
Published list or reimbursement prices for Neomycin Sulfate presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.
| Country | Product | Strength | Pack | Price | Type | Source | As of |
|---|---|---|---|---|---|---|---|
| Iceland | Neomycin | 500mg | pakki | 18,759.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Saudi Arabia | Neomycin Nasal Spray | 2.40 SAR | public | SFDA | 2026-09-01 | ||
| Saudi Arabia | Statrol Eye Drops | 10.85 SAR | public | SFDA | 2026-09-01 |
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. Because this DIN is marketed in Canada, supply normally comes through the Canadian channel; where the Canadian presentation is short or discontinued, the registrations above show which regulated markets hold an equivalent that can be imported under the Special Access Programme or for clinical comparator use. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Neopro 325 (DIN 02530619) marketed in Canada?
Yes. Health Canada lists DIN 02530619 as Marketed as of 27 Sep 2022.
Who holds the Canadian licence for this product?
Can-Vet Animal Health Supplies Ltd. is the company of record in the Health Canada Drug Product Database.
Is Neomycin Sulfate registered outside Canada?
Yes — Nexara Health has matched 114 registrations in 11 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02530619, status date 2022-09-27; national medicine registries: BDA, DH Drug Office, FDA NDC, FEST (DMP), Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, NHS dm+d VMP, SFDA, TFDA, TITCK, URPL RPL; price sources: Lyfjastofnun lyfjaverdskra, SFDA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02530619, status date 2022-09-27; national medicine registries: BDA, DH Drug Office, FDA NDC, FEST (DMP), Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, NHS dm+d VMP, SFDA, TFDA, TITCK, URPL RPL; price sources: Lyfjastofnun lyfjaverdskra, SFDA.
Health Canada Drug Product Database (DPD), DIN 02530619, status date 2022-09-27; national medicine registries: BDA, DH Drug Office, FDA NDC, FEST (DMP), Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, NHS dm+d VMP, SFDA, TFDA, TITCK, URPL RPL; price sources: Lyfjastofnun lyfjaverdskra, SFDA. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.